[Multidrug-resistant Pseudomonas aeruginosa T]

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Multidrug-resistant (MDR) Pseudomonas aeruginosa strains resistant to carbapenems, fluoroquinolones, and amikacin pose a significant challenge in Japan.
• Nosocomial outbreaks of MDR P. aeruginosa infections are increasingly problematic in healthcare settings.
• MDR P. aeruginosa isolates constitute approximately 2.5% of all P. aeruginosa isolates in medical facilities.

Purpose of the Study:

• To address the challenge of multidrug resistance in P. aeruginosa.
• To develop a rapid detection method for specific enzyme-producing MDR P. aeruginosa strains.

Main Methods:

• Characterization of multidrug-resistant P. aeruginosa strains, focusing on antibiotic resistance profiles.
• Identification of key resistance enzymes, including metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae.
• Development and validation of an immunochromatographic assay for enzyme detection.

Main Results:

• Clonal expansion of P. aeruginosa strains with high-level resistance (MICs > 64 microg/mL) was observed in community hospitals.
• The majority of these highly resistant strains produced metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae.
• The developed immunochromatographic assay demonstrated ease of use and reliability for detecting these enzyme-producing strains.

Conclusions:

• The emergence of highly resistant MDR P. aeruginosa strains is a critical issue in Japan.
• The developed immunochromatographic assay provides a valuable tool for the rapid identification of these specific resistant strains.
• This assay can aid in infection control and timely management of MDR P. aeruginosa outbreaks.